The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity

Kimberly Ann-Bordun,Sheena Premecz,Megan daSilva,Soma Mandal,Vineet Goyal,Tamara Glavinovic,Matthew Cheung,David Cheung,Christopher W. White,Rakesh Chaudhary,Darren H. Freed,Hector R. Villarraga,Joerg Herrmann,Manish Kohli,Amir Ravandi,James A. Thliveris,Marshall Pitz,Pawan K. Singal,Sharon L. Mulvagh,Davinder S. Jassal

The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity

2015

The current basic science study evaluates the utility of cardiac biomarkers and echocardiography using tissue velocity imaging and strain rate imaging for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity.

Keywords:

Bevacizumab
Heart failure
Diabetes mellitus
Cardiac biomarkers
Cardiotoxicity
Tissue velocity
Strain rate imaging
Sunitinib
Medicine
Cardiology
Internal medicine
early detection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations